Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-004474-26Phase 3Active
Phase 3 trial of cholecalciferol in diffuse large B-cell lymphoma (DLBCL) (2 arms), sponsored by Fondazione Italiana Linfomi. Primary endpoint: Primary safety of vitamin D supplementation. Started Oct 2020; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-004474-26.